Toggle navigation
Rhema
Stem
HOME
ABOUT US
TECHNOLOGY
Services
Pipeline
Intellectual Property and Patents
CONTACT
Pipeline
Technology
Services
Pipeline
Intellectual Property and Patents
Molecules Targeting Colorectal Cancer Stem Cells
Objective is to identify molecules that can target colon cancer stem cells.
5 “hit” compounds identified.
Currently in pre-clinical development.
Initial indication is treatment of colorectal cancer.
Additional indications include solid tumors.
Molecules Targeting Metastatic Cancer Stem Cells In Colorectal Cancer
Objective is to identify molecules that can block the spread of colorectal cancer (Metastasis).
Currently in pre-clinical development.
Initial indication is treatment of colorectal cancer metastasis.
Additional indications include solid tumors.
Stem Cell Therapy
Objective is to use normal colon stem cells in inflammatory bowel diseases.
Currently in pre-clinical development.
Initial indication is treatment of Ulcerative colitis.
Additional indications include other inflammatory bowel diseases.